300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Mobile
Energy
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Biotechnology
Legal
Renewable Energy
Software
Crowdfunding
Venture Capital
Social
Recruiting
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Web3
Publishing
Mobile Apps
Medical
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Theatre
Internet
Mobile Advertising
Android
Proptech
Enterprise
Impact
Sustainability
Hardware
Community
Biotech
Transportation
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Haiti
Guinea
Lesotho
Kyrgyzstan
Norway
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Oman
Romania
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Mozambique
Malta
Mauritius
Namibia
Nicaragua
Serbia
Panama
Australia
Uzbekistan
New Zealand
Morocco
Sri Lanka
Saudi Arabia
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Jamaica
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Ecuador
Bahrain
Bolivia
Belize
Algeria
Italy
Estonia
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Bahamas
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Baker & Eastlack Ventures, VC Fund

Baker & Eastlack Ventures

VC Fund

San Diego, United States

Baker & Eastlack Ventures is a VC fund in San Diego focused on Medical and Health Care. Baker & Eastlack Ventures invests in early stage medical devices and diagnostics.They have deep experience in patient care, healthcare, investing, and corporate operations.

Total investments:
7
Last investment:
Lead investor:
14%

Last updated:

Industries Baker & Eastlack Ventures invests in

MedicalHealth CareMedical DeviceBiotechnologyBiopharma

Stages Baker & Eastlack Ventures invests in

Venture - Series UnknownSeed

Countries Baker & Eastlack Ventures invests in

United States

Contacts

NameEmailPhoneSocials
Kenneth Baker
Robert Eastlack

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 4 (57%)
  • Health Care 4 (57%)
  • Medical Device 4 (57%)
  • Biotechnology 3 (43%)
  • Biopharma 2 (29%)
See all 15 industries →

Stage

  • Venture - Series Unknown 4 (57%)
  • Seed 3 (43%)

Team

NameTitleInvestmentsLinksEmail
Kenneth Baker Partner & Co-Founder
Partner & Co-Founder Total investments: 0 Find email
Robert Eastlack Partner & Co-Founder
Partner & Co-Founder Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
OcuDoc Mobile is a product of OcuDoc, Inc, a Columbus, Ohio-based MedTech startup that develops and markets innovations in eyecare technologies. OcuDoc Mobile is the first and only standalone smartphone app that can provide accurate, fast, objective autorefraction and Telerefraction, all without the need for additional equipment. $2.5M / Venture - Series Unknown / Feb 15, 2023
MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients. Seed / Oct 08, 2018
Clarify Medical is innovating a well-established treatment, UVB therapy, to become easier, more convenient, more empowering, and more connected for psoriasis, eczema and vitiligo patients. The company also focused on developing innovative technology, products, and services that improve care for people with chronic skin conditions.Clarify Medicalindicated for the localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of UVB light therapy, helping to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress, and satisfaction. $1M / Venture - Series Unknown / Jul 03, 2018
Lentechs is a medical device company that develops a novel soft bifocal contact lens. The company is headquartered in Columbus, Ohio. Seed / Mar 22, 2018
Neurvana Medical is dedicated to the development of neurovascular therapeutic devices. $3.2M / Venture - Series Unknown / Oct 23, 2017
UroDev Medical designs devices to improve the quality of life for people with Spinal Cord Injury and Disease. Their first product, The Connected Catheter, will revolutionize the way millions of people deal manage their bladders. $3.2M / Seed / Sep 27, 2017
Kurin® is a privately held, certified minority owned business dedicated to engineering better healthcare through innovative, cost-effective, clinician-approved technologies.Building on the successful invention, clinical adoption and corporate acquisition of Curos™ disinfecting port protectors, Kurin is focusing its depth of experience inmedical device engineering, marketing, sales and service, to tackle the persistent and costly fallout of false positive blood cultures. With agile development capabilities and intense customer focus, we expect the Kurin Lock technology to quickly gain caregiver acceptance, reduce blood culture contamination and become the standard of care in hospitals. $2.3M / Venture - Series Unknown / Oct 06, 2016

Co-Investors

Ivernet Holding SAPI de CV 1 deal together
OC Service Academy Angels 1 deal together
Particular Ventures Particular Ventures 1 deal together Primer Capital Primer Capital 1 deal together Santa Barbara Angel Alliance Santa Barbara Angel Alliance 1 deal together
Storm Industries Storm Industries 1 deal together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Mobile
Energy
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Biotechnology
Legal
Renewable Energy
Software
Crowdfunding
Venture Capital
Social
Recruiting
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Web3
Publishing
Mobile Apps
Medical
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Theatre
Internet
Mobile Advertising
Android
Proptech
Enterprise
Impact
Sustainability
Hardware
Community
Biotech
Transportation
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Haiti
Guinea
Lesotho
Kyrgyzstan
Norway
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Oman
Romania
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Mozambique
Malta
Mauritius
Namibia
Nicaragua
Serbia
Panama
Australia
Uzbekistan
New Zealand
Morocco
Sri Lanka
Saudi Arabia
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Jamaica
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Ecuador
Bahrain
Bolivia
Belize
Algeria
Italy
Estonia
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Bahamas
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Baker & Eastlack Ventures invest in?

Baker & Eastlack Ventures invests primarily in Medical, Health Care and Medical Device startups, most often at Venture - Series Unknown and Seed stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Baker & Eastlack Ventures?

Public channels for Baker & Eastlack Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Baker & Eastlack Ventures?

The team at Baker & Eastlack Ventures includes Kenneth Baker (Partner & Co-Founder) and Robert Eastlack (Partner & Co-Founder). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Baker & Eastlack Ventures Baker & Eastlack Ventures Find emails